Paige Mahaney - Chief Scientific Officer at C4 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
CCCC on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paige Mahaney since 08 Feb 2025

Holdings reported by Paige Mahaney for C4 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 99,356 $256,338 $2.58 28 Oct 2025 Direct
Stock Option (Right to Buy) 42,400 14 Feb 2025 Direct Common Stock

Transactions reported by Paige Mahaney for C4 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.